Laboratory for Dendritic Cell Immunobiology, RIKEN Research Center for Allergy and Immunology, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama, Kanagawa 230-0045, Japan.
Immunity. 2011 Dec 23;35(6):958-71. doi: 10.1016/j.immuni.2011.10.014. Epub 2011 Dec 15.
Plasmacytoid dendritic cells (pDCs) are characterized as type I interferon-producing cells that engage endosomal toll-like receptors (TLRs) and exclusively express sialic acid binding Ig-like lectin (Siglec)-H. However, their role in vivo remains unclear. Here we report a critical role for pDCs in the regulation of inflammation and T cell immunity in vivo by using gene-targeted mice with a deficiency of Siglec-H and conditional ablation of pDCs. pDCs were required for inflammation triggered by a TLR ligand as well as by bacterial and viral infections. pDCs controlled homeostasis of effector and regulatory CD4(+) T cells. Upon antigenic stimulation and microbial infection, pDCs suppressed the induction of CD4(+) T cell responses and participated in the initiation of CD8(+) T cell responses. Furthermore, Siglec-H appeared to modulate the function of pDCs in vivo. Thus, our findings highlight previously unidentified roles of pDCs and the regulation of their function for the control of innate and adaptive immunity.
浆细胞样树突状细胞 (pDCs) 的特征是能够产生 I 型干扰素的细胞,其能够结合内体 Toll 样受体 (TLRs),并且仅表达唾液酸结合免疫球蛋白样凝集素 (Siglec)-H。然而,其在体内的作用仍不清楚。在此,我们通过使用 Siglec-H 基因缺失和 pDCs 条件性缺失的基因靶向小鼠,报告了 pDCs 在体内炎症和 T 细胞免疫调节中的关键作用。pDCs 对于 TLR 配体以及细菌和病毒感染引发的炎症是必需的。pDCs 控制效应器和调节性 CD4(+)T 细胞的稳态。在抗原刺激和微生物感染时,pDCs 抑制 CD4(+)T 细胞反应的诱导,并参与 CD8(+)T 细胞反应的起始。此外,Siglec-H 似乎在体内调节 pDCs 的功能。因此,我们的发现强调了 pDCs 的先前未被识别的作用及其功能调节对于固有和适应性免疫的控制。